← Back to Conditions

Restless legs

disorder
SNOMED 32914008CUI C0035258

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Iron pentacarbonyl

substance

Iron carbonyl

substance

Carbamazepine

substance

Clonazepam

substance

Rotigotine

substance

Clinical Trials

18
Total Trials
1
Recruiting
7
With Results

Recent Trials

Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

NCT05003648Phase 4Recruiting24 enrolled

Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study

NCT01668667Phase 4Completed501 enrolled

Long-term Study Of Ropinirole In Restless Legs Syndrome

NCT00329602Phase 4Completed404 enrolled

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

NCT00375284Phase 4Completed404 enrolled

Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances

NCT00356096Phase 4Completed404 enrolled
View all 18 trials on ClinicalTrials.gov

Related Conditions

Secondary restless legs syndrome(child)
Restless leg syndrome in pregnancy(child)
Sleep related movement disorder(parent)
Disorder of lower extremity(parent)

Quick Facts

SNOMED CT
32914008
UMLS CUI
C0035258
Fully Specified Name
Restless legs syndrome (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
5
Clinical Trials
18
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.